Objective
Depression is a devastating disease with high incidence and societal cost involving dysfunction of noradrenergic and serotonergic brain circuits. Current antidepressants are not ideal with less than half of the patients treated attaining complete remission using a single antidepressant whilst others exhibit partial, refractory or intolerant responses.
There is a need for novel antidepressants and neuropeptides represent an interesting lead. Nociceptin/orphanin FQ (N/OFQ) and its receptor (NOP) constitute a novel peptide-receptor system expressed in areas of the brain involved in emotional processing.
The limited number of NOP antagonists available produce antidepressant-like effects in mice and NOP receptor knockouts display antidepressant-like phenotypes. This project is to validate the NOP receptor as an antidepressant target. In vitro assays will be employed to characterize the pharmacological profile of novel NOP antagonists.
In vivo studies in rats and mice will characterize acute and chronic actions of N OP antagonist-induced effects in various models of depression. Mechanistically, interactions between monoamines and N/OFQ-NOP receptor system will be evaluated with reference to monoaminergic pathways, noradrenergic/serotonergicreceptors and monoamine release.
This proposal brings together researchers with expertise both necessary and sufficient for this project which is hoped will provide evidence for NOP antagonists as a novel class of antidepressants.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2002-MOBILITY-7
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
IIF - Marie Curie actions-Incoming International Fellowships
Coordinator
FERRARA
Italy
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.